logo

Entrx Corporation (ENTX)



Trade ENTX now with
  Date
  Headline
9/23/2019 8:11:22 AM Entera Bio Reports Positive Results From A Phase 2 PK/PD Study Of Oral PTH (1-34) In Patients With Hypoparathyroidism
8/20/2019 7:04:11 AM Entera Bio Q2 Loss Per Share $0.12 Vs Loss $0.11 Last Year
7/2/2019 7:07:11 AM Entera Begins Phase 2 Dose Ranging Study For Oral PTH
1/22/2019 8:09:37 AM Entera Bio Q3 Loss Per Share $0.45 Vs Loss $0.85 Last Year
1/10/2019 7:02:44 AM Entera Bio Appoints Gerald Ostrov To Board
11/8/2018 8:08:30 AM Entera Bio Says Positive Results From Part 1 Of Phase 2 PK/PD Study Of Oral PTH (1-34) For Hypoparathyroidism
9/21/2018 9:15:53 AM Entera Bio Appoints Arthur Santora As Its New Chief Medical Officer
8/20/2018 4:08:19 PM Entera Bio Q2 EPS $13.97 Vs. $77.87 Year Ago
8/9/2018 12:00:56 PM Entera Bio AppointS Gerald Lieberman As Chairman Of Board
7/2/2018 4:13:26 PM Entera Bio Closes IPO Of 1.40 Mln Units
6/28/2018 8:54:30 AM Entera Bio Prices IPO Of 1.40 Mln Units At Combined Price Of $8.00 Per Unit
  
 
>